- Home
- ALT vs CABO Comparison
ALT vs CABO Comparison
Compare ALT & CABO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ALT | CABO |
|---|---|---|
| Founded | 1997 | 1980 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Cable & Other Pay Television Services |
| Sector | Health Care | Telecommunications |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 421.5M | 425.5M |
| IPO Year | 2005 | 2015 |
Fundamental Metrics
Financial Performance| Metric | ALT | CABO |
|---|---|---|
| Price | $2.99 | $44.08 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 6 | 4 |
| Target Price | $17.67 | ★ $125.67 |
| AVG Volume (30 Days) | ★ 3.3M | 229.4K |
| Earning Date | 05-08-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 25.37 | N/A |
| EPS | N/A | ★ 6.12 |
| Revenue | $41,000.00 | ★ $1,501,423,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $6.83 |
| P/E Ratio | ★ N/A | $6.46 |
| Revenue Growth | ★ 105.00 | N/A |
| 52 Week Low | $2.56 | $33.38 |
| 52 Week High | $6.44 | $180.74 |
Technical Indicators
Market Signals| Indicator | ALT | CABO |
|---|---|---|
| Relative Strength Index (RSI) | 54.11 | 50.72 |
| Support Level | $2.87 | $39.52 |
| Resistance Level | $3.09 | $44.46 |
| Average True Range (ATR) | 0.16 | 3.58 |
| MACD | -0.00 | 0.54 |
| Stochastic Oscillator | 41.07 | 88.00 |
Price Performance
Historical ComparisonAbout ALT Altimmune Inc.
Altimmune Inc is a late clinical-stage biopharmaceutical company developing therapies for patients with serious liver diseases. The Company's key candidate, pemvidutide, is a dual-action therapy targeting both glucagon and GLP-1 receptors in a balanced 1:1 ratio in development for the treatment of metabolic dysfunction-associated steatohepatitis (MASH), alcohol use disorder (AUD), and alcohol-associated liver disease (ALD). The company also plans to pursue additional indications for pemvidutide that leverage the differentiated clinical profile of pemvidutide.
About CABO Cable One Inc.
Cable One Inc is a telecommunications company that generates revenue from providing broadband, voice, and video services to both residential and business customers. The company derives majority of its revenue from data and video services, which are subscription-based and billed monthly. The company also offers Sparklight TV, an Internet Protocol Television (IPTV) service that enables customers using the Sparklight TV app to stream video channels from the cloud. Additionally, the company earns advertising revenue by selling airtime on its video channels, and it provides voice services over Internet protocols.